AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionAlTi Global, Inc.
Latest Disclosed Ownership18,248 shares
Latest Disclosed Value $ 3,968,852
AlTi Global, Inc. reports 3.47% decrease in ownership of 4AB / AbbVie Inc.

On May 7, 2026 - AlTi Global, Inc. filed a 13F-HR form disclosing ownership of 18,248 shares of AbbVie Inc. (DE:4AB) valued at $3,383,179 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 18,904 shares of AbbVie Inc.. This represents a change in shares of -3.47% during the quarter. The current value of the position is $3,439,748 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ABBVIE COM 00287Y109 18,248 -656 -3.47 3,969 -8.13 0.0863
2026-02-13 2025-12-31 13F ABBVIE COM 00287Y109 18,904 -28,110 -59.79 4,319 -60.32 0.0926
2025-11-06 2025-09-30 13F ABBVIE COM 00287Y109 47,014 -1,090 -2.27 10,885 20.40 0.2554
2025-07-31 2025-06-30 13F ABBVIE COM 00287Y109 48,104 4,094 9.30 9,042 -1.94 0.2268
2025-05-15 2025-03-31 13F ABBVIE COM 00287Y109 44,010 -17,935 -28.95 9,221 -15.32 0.2417
2025-02-14 2024-12-31 13F ABBVIE COM 00287Y109 61,945 -6,590 -9.62 10,888 -19.55 0.2628
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 68,535 11,465 20.09 13,534 38.27 0.3253
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 57,070 -20,074 -26.02 9,789 -30.32 0.2629
2024-05-15 2024-03-31 13F ABBVIE COM 00287Y109 77,144 51 0.07 14,048 17.58 0.3906
2024-02-14 2023-12-31 13F ABBVIE COM 00287Y109 77,093 77,093 11,947 0.3655
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.